五洲医疗(301234) - 投资者关系活动记录表

Group 1: Company Development Plans - The company focuses on the field of single-use sterile infusion medical consumables, including innovations in syringes, infusion and blood transfusion devices, and medical puncture needles [1][2] - The company aims to deepen technological innovation and expand market channels to establish a solid foundation for high-quality and sustainable development [1][2] Group 2: Investor Engagement - The investor relations activity was conducted via an online platform on September 15, 2025, from 14:00 to 17:00 [1] - The company expressed gratitude for investor support and emphasized the importance of referring to official disclosures for significant company matters [2]